A ntibiotics are frequently used in hospice care. Approximately 27% of hospice beneficiaries receive a least 1 antibiotic in the final week of life. 1 Despite this high prevalence of use, healthcare providers have minimal guidance to support antibiotic decision-making for terminally ill individuals who have forgone further curative therapy. Although medication use in hospice care focuses primarily on symptom management rather than curative therapy, the effectiveness of antibiotics to improve symptoms and quality of life is largely unkown. [2] [3] [4] Thus, decisions to use antibiotics must take into account differences in preferences between individuals, family members, and hospice providers as well as the risk of adverse events, potential for antibiotic resistance, and healthcare system costs.
Several previous studies that have described antibiotic use in hospice care 1, [5] [6] [7] [8] suggest that antibiotics are frequently prescribed for individuals with urinary tract (UTIs), respiratory tract (including pneumonia), skin and soft tissue, and bloodstream infections, but our analysis of data from a nationally representative sample of hospice beneficiaries observed that only 15% who received antibiotics had a documented infectious diagnosis. 1 We previously described the characteristics of individuals who received a prescription for antibiotics upon discharge to hospice care because these medications are often continued after hospice admission. 5 In that study, we observed that the most frequently prescribed antibiotics were inconsistent with the distribution of documented infections in those individuals. Our previous study did not clarify why people received antibiotics upon discharge to hospice care. In this study, we quantified the documented clinical intentions for antibiotics prescribed upon discharge from acute care to hospice care. A better understanding of these intentions and contextual variables regarding these prescribing decisions may inform interventions to optimize their use at the end of life.
METHODS

Study Design and Participant Population
This was a retrospective cohort study of adults (≥18) who received an outpatient prescription for antibiotics upon discharge from Oregon Health & Science University Hospital (OHSU) to hospice care between January 1, 2009, and December 31, 2011. During this period, OHSU was a 544-bed, academic, acute-care, tertiary referral hospital in Portland, Oregon. These individuals and their characteristics were described in a previous study. 5 Briefly, participants were identified using discharge disposition data collected by the Department of Care Management and medication data on discharge summaries in the electronic medical record. If participants had multiple discharges to hospice during the study period, only the first discharge was included for each. We excluded individuals who died before discharge, whose discharge disposition was unknown, or who were admitted to the hospital for less than 24 hours. The OHSU institutional review board approved this study.
Data Collection and Variables
We comprehensively reviewed each participant's medical record, including daily progress notes, infectious disease and palliative care service consultation notes, and discharge summaries. Data were collected using manual medical record review on a standardized data extraction form created using the Research Electronic Data Capture application. 9 Additional administrative, demographic, and comorbidity data were collected from the Pharmacy Research Repository, a longitudinal repository of healthcare data created in partnership with the Oregon Clinical and Translational Institute Research Data Warehouse at OHSU. We defined aggregate comorbidity burden using the Charlson Comorbidity Index. 10 Our primary outcomes of interest were the infectious indication, documented rationale, and contextual variables (e.g., whether antibiotics were to continue to treat an existing infection, known individual or family preferences) of each antibiotic prescription. Although participants may have had multiple infections during their hospital stay, we focused on the primary indication or indications for which antibiotics were prescribed upon discharge to hospice care. Indication data were documented and classified into the following categories: bloodstream infections, septicemia or endocarditis, pneumonia, UTIs, sepsis, gastrointestinal infections, pressure ulcers and skin and soft tissue infections, respiratory tract infections, and other infections. We also documented if participants were prescribed a single antibiotic to treat more than one infection.
We specifically examined the documented rationale for antibiotics, which we categorized as treatment of an active infection or prophylaxis. When the rationale for antibiotic use was not explicitly documented, we made inferences based on documentation of symptoms, diagnoses, and microbiological culture data. We defined prophylactic therapy as receipt of antibiotic treatment without a documented infectious indication, with negative culture or lack of culture data, and with no documentation of infectious signs or symptoms. We defined active treatment as receiving antibiotics for a documented infection or for participants with a positive culture and documented associated signs and symptoms of infection. For participants with active infections, we also recorded any additional documented rationale or intention for treatment. Intention of treatment could be classified as curative, palliative, suppressive, or prescribed according to family or participant preference. These categories were not mutually exclusive.
We determined whether the antibiotics prescribed on discharge were a continuation of treatment initiated in the hospital or initiated upon discharge to hospice, whether antibiotics were prescribed empirically, and whether palliative care specialists were consulted on whether to use antibiotics. Continuation of therapy started in the hospital was defined as antibiotics received in the hospital and upon discharge for the same indication and rationale. If the infectious indication or intent for antibiotic treatment upon discharge was not documented, continuation of therapy was determined based on continuation of the current antibiotic at the same dose as prescribed during the hospital visit or documented conversion to another antibiotic. We defined empiric therapy as treatment in the absence of culture data and presence of an active infection based on documented signs and symptoms of infection. Lastly, we assessed whether the palliative care service was consulted or if notes from the palliative care service indicated involvement with discharge medications.
We also examined participant preferences for the intensity of end-of-life care interventions using responses on Physician Orders for Life Sustaining Treatment (POLST) forms-medical orders that clarify preferences and direct treatment decisions at the end of life. [11] [12] [13] The current POLST form does not directly address use of antibiotics but included a specific section on antibiotic use until May 2011. During that time, people could select from 3 out-of-hospital orders for antibiotic use: "No antibiotics, use other measures to relieve symptoms," "Determine use or limitation of antibiotic when infection occurs," and "Use antibiotics if medically indicated."
Lastly, we documented duration of antibiotic use based on number of days remaining in the antibiotic course at discharge. Total duration of antibiotics (including those prescribed at discharge) was determined from medical record review and number of days since antibiotic therapy initiation. Number of refills authorized on the discharge prescription was also recorded.
Statistical Analysis
All analyses were descriptive, and results are presented as means with standard deviations, medians with interquartile ranges, and frequencies with percentages, as appropriate. All analysis was performed using SAS version 9.2 (SAS Institute, Inc., Cary, NC).
RESULTS
Of 845 individuals discharged to hospice care over the 3-year study period, 149 (17.6%) received 159 antibiotic prescriptions on discharge. Individual characteristics are described in Table 1 . Briefly, mean age was 63.6 AE 14.2, 91 (61.1%) had a hospice diagnosis of cancer, and 121 (81.2%) were discharged to a community-based hospice. Most (84.8%) had a palliative care consultation during their admission before hospital discharge, but only 61.7% of these consultations specifically addressed discharge medications.
A POLST form was documented as having been completed for 104 (70.3%) participants, although only 92 (61.7%) had a POLST form available to view in the medical record that included specific orders for the degree of life-sustaining measures they would like implemented. Documented POLST orders are displayed in Table 1 . Orders for antibiotic use were available for only 72 (48.3%) participants. Most forms documented orders to use antibiotics if medically indicated (47.2%) or to determine use and limitations of antibiotics at the time an infection occurred (43.1%). Only 7 forms (9.7%) contained orders to avoid future antibiotic use.
The explicit rationale for each antibiotic prescription on discharge was documented in the medical record for only 72 (45.3%) prescriptions (data not shown). For 127 (79.9%) prescriptions, antibiotics prescribed upon discharge were to continue a course started in the hospital, of which 96 (75.6%) prescriptions were for the same class of antibiotics and only 69 (54.3%) had an infection that was verified by culture data before discharge. For 84 (52.8%) prescriptions, antibiotics were given for treatment of an active infection in the hospital. In 25 prescriptions (15.7%), antibiotics were prescribed as prophylaxis based on our definition. Of the 72 prescriptions with an explicit rationale documented in the medical record, 27 (37.5%) indicated that the intent was curative, 19 (26.4%) prophylaxis, and 16 (22.2%) to suppress an infection. Additionally, for 14 (19.4%) prescriptions, participants or their family members specifically wanted treatment with antibiotics. Only 7 (9.7%) prescriptions specifically indicated that antibiotics were prescribed for palliative reasons.
The distribution of indications for antibiotic prescriptions is displayed in Figure 1 . These data are also displayed stratified according to active infection status and intended duration of treatment in Table 2 . The most frequently documented indications were pneumonia (19.5%), UTIs (18.9%), and gastrointestinal infections (17.0%), although a significant proportion of participants also received prescriptions for typically more serious infections, including intra-abdominal infections (10.7%) and bloodstream infections, septicemia, or endocarditis (11.9%). Median duration of antibiotic prescriptions ranged from 8.5 to 26.0 days and varied according to indication.
DISCUSSION
We aimed to better understand the clinical intentions of antibiotics prescribed to individuals upon discharge to hospice care. Improving this understanding could help to guide medication decisions and optimize transitions of care in this population. People were frequently prescribed antibiotics to continue or complete treatment that was initiated in the hospital, and most received antibiotics for treatment of an active infection. Furthermore, most lacked explicit documentation of the rationale for antibiotic treatment. In individuals with explicit documentation, the most common clinical rationales for antibiotic prescriptions were curative or suppressive treatment or prophylaxis. In addition, clinical notes frequently indicated individual or family member preference for antibiotic use. In contrast, we rarely observed specific intentions to manage symptoms of an infection.
The most frequently documented indications were pneumonia, UTIs, and gastrointestinal infections, although a significant proportion of participants also received prescriptions for typically more serious infections, including intra-abdominal infections and bloodstream infections or endocarditis. The intended duration of antibiotic prescriptions varied according to indication. Participants receiving treatment for intra-abdominal infections and bloodstream infections were less likely to have an active infection but more likely to receive treatment for a longer duration. In individuals with chronic liver disease, long-term treatment with antibiotics is often indicated for secondary prevention of spontaneous bacterial peritonitis, which is consistent with our observed data.
A clear understanding of the rationale for continued antibiotic treatment may be especially important during the transitions to hospice care and as goals of care change. Previous studies have attempted to identify types of individuals who are most often prescribed antibiotics at the end of life, 1, 5, 6 but few studies have described the clinical intentions of antibiotics prescribed upon transition to hospice care. Furthermore, there are few standards of care that provide guidance for use of antibiotics in individuals receiving hospice care or in the last stages of life.
14 Symptom relief in individuals with UTIs and sepsis has been previously documented, but there is limited evidence of the risks and benefits of antibiotics for other indications in this population. 4, 15 Similarly, data regarding optimal duration of antibiotic treatment are limited. In the absence of these data, documentation of the rationale for continued treatment and emphasis on goal-directed patient education and shared decision-making may help to optimize antibiotic use for individuals transitioning to hospice care.
Incorporating antibiotic preferences as part of the advanced care planning process may also help optimize antibiotic use in hospice care. 13, 14 Data from completed POLST forms suggested that most people wanted to receive antibiotics if medically indicated or to determine use at the time an infection occurred. Furthermore, clinical notes indicated that nearly 20% of participants or family members specifically wanted to be treated with antibiotics. Infections are common near the end of life and may often be the final cause of death. A collaborative evaluation of individual and family preferences, expected benefits, potential adverse effects, and treatment burden would help to improve medication management and align treatment with the individual's preferences and goals. 14, 16, 17 Collaborative evaluation and shared decision-making between individuals, caregivers, and providers may be especially important for individuals who lack documented rationale for antibiotics or for individuals and families who do not specifically request continuation of antibiotics.
The primary limitation of this study was that we relied on documentation in medical records to discern the rationale and clinical intentions of antibiotic prescriptions. This required us to make some assumptions to determine the rationale for prescribing antibiotics. Our use of standardized abstraction forms aimed to minimize subjective interpretation and misclassification, but because our definitions were based on information obtained through medical record review, and this information was often lacking, it is likely that some misclassification occurred. Hospice care providers relying on medical records to understand care decisions also face this challenge. Furthermore, many factors may contribute to medication decisions upon discharge to hospice that may not be documented in the medical record. Individual and family preferences, symptom severity, and prognosis may all contribute to these Figure 1 . Distribution of indications for antibiotics prescribed upon discharge to hospice care (N = 159). decisions. In addition, individual preferences and goals of care may change with changes in health status and during or after discussions with providers, palliative care specialists, and family or loved ones. A second limitation is that our data reflect practices at a single academic health center between 2009 and 2011 and thus may not be representative of the present time or other hospitals or regions. Furthermore, few participants had a documented clinical rationale for antibiotic use, which limits interpretation of these results. Further research may help characterize rationale for use, benefits of treatment, and risks associated with antibiotic therapy.
In conclusion, our study suggests that acute care providers frequently prescribe antibiotics upon discharge to hospice care with the intention of curing infections despite a shift from curative to palliative goals of care. Antibiotics were also frequently prescribed in the absence of culture data and to treat serious, systemic infections. Future work should address clinical outcomes of this population and possible adverse events of antibiotic use, including antibiotic-resistant infections, readmission to the hospital, and time until death.
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